Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07276750 · ClinicalTrials.gov registry record · NA
Coaching and Leadership in Autism Support Settings
A NA study of Autism Spectrum Disorder (ASD), sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 373
- Enrollment target
- 1
- Study location
NCT07276750: Recruiting NA study of Autism Spectrum Disorder (ASD), sponsored by University of California, Los Angeles.
NCT07276750 is a NA study of Autism Spectrum Disorder (ASD) that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 373 participants, above the 79-participant average among 16 other Autism Spectrum Disorder (ASD) trials with a reported enrollment target (372% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07276750, a NA study of Autism Spectrum Disorder (ASD), is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 373 participants
- Enrollment target
- 1
- Study location
Study Summary
Schools serve a large number of autistic children, yet face two critical gaps that stifle the delivery of evidence-based practices: 1) an intervention gap characterized by limited availability of evidence-based practices educators can use to address externalizing behaviors when they occur in the classroom; and 2) an implementation gap consisting of insufficient evidence-based practice fidelity and sustainment over time. To address these gaps, this project proposes a hybrid type 2 effectiveness-implementation trial that simultaneously tests: 1) the clinical effectiveness of an efficient, educator-delivered clinical intervention to reduce autistic children's externalizing behaviors (Research Units in Behavioral Interventions in Educational Settings; RUBIES), and 2) the implementation effectiveness of an organizational implementation strategy designed specifically to enhance sustainment of evidence-based practices in public schools (Helping Educational Leaders Mobilize evidence; HELM). Consistent with the National Institute of Mental Health (NIMH)'s experimental therapeutics approach, the project also examines the mechanisms through which RUBIES impacts clinical outcomes and through which HELM influences implementation outcomes. The proposed study directly responds to high priority research areas of the US Department of Health and Human Services Interagency Autism Coordinating Committee's Strategic Plan for Autism Research, which calls for expanded research on the translation of proven-efficacious interventions into the community, NIMH Strategic Priority 3.3 to test interventions for effectiveness in community practice settings, and NIMH Strategic Priority 4.2 to expedite adoption, sustained implementation, and continuous improvement of evidence-based mental health services. If successful, this study will have substantial public health impact because it will produce an effective intervention for a prevalent problem among a high impact population in schools across the U
Primary Outcome
The Sutter Eyberg Student Behavior Inventory-Revised (SESBI-R) is a teacher-report measure used to assess conduct problems in youth ages 2-16. It contains 38 items where teachers are able to indicate the current frequency of behavior problems (Never to Always) and determine whether or not they find the behaviors to be problematic.
Conditions Studied
Interventions
- OTHER HELM
- OTHER RUBIES
- OTHER Educator Psychoeducation
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 373 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2030-08-31 |
| Phase | NA |
What NCT07276750 shows while recruiting
NCT07276750 is an interventional study that assigns participants to a tested intervention. The registered 373 participants enrollment target is mid-sized for trials with a published cap, above the 79-participant average among 16 other Autism Spectrum Disorder (ASD) trials with a reported enrollment target (372% higher).
The record links to 1 condition, with Autism Spectrum Disorder (ASD) appearing as the primary indexed condition, and to 3 interventions - of which HELM is the first listed.
NCT07276750 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07276750 about?
NCT07276750 is a clinical study titled "Coaching and Leadership in Autism Support Settings". Schools serve a large number of autistic children, yet face two critical gaps that stifle the delivery of evidence-based practices: 1) an intervention gap characterized by limited availability of evidence-based practices educators can use to address externalizing behaviors when they occur in the cla...
What is the current status of trial NCT07276750?
This trial is currently recruiting. It is a NA study. The enrollment target is 373 participants. The study started on 2026-02-01. Estimated completion is 2030-08-31.
What conditions does trial NCT07276750 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder (ASD).
What interventions are being tested in trial NCT07276750?
The interventions under investigation include: HELM (OTHER), RUBIES (OTHER), Educator Psychoeducation (OTHER).
Who is sponsoring clinical trial NCT07276750?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07276750 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder (ASD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07276750's enrollment target sits among peer trials
373 1st of 16 higher than 16 of 16 other Autism Spectrum Disorder (ASD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder (ASD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ADAPT: Approach to Dance for Autism
RECRUITING · NA
-
External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms
RECRUITING · NA
-
Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism
RECRUITING · NA
-
Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental Disabilities
RECRUITING · NA
-
A Trial of the Launching! to Adulthood Program
RECRUITING · NA
-
Motivation for Daily Living Skills
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- NCT05318105 · 372 participants · NA
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
- NCT06797635 · 372 participants · Phase 2
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI